Details for New Drug Application (NDA): 208813
✉ Email this page to a colleague
The generic ingredient in TOREMIFENE CITRATE is toremifene citrate. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the toremifene citrate profile page.
Summary for 208813
Tradename: | TOREMIFENE CITRATE |
Applicant: | Rising |
Ingredient: | toremifene citrate |
Patents: | 0 |
Pharmacology for NDA: 208813
Mechanism of Action | Selective Estrogen Receptor Modulators |
Medical Subject Heading (MeSH) Categories for 208813
Suppliers and Packaging for NDA: 208813
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TOREMIFENE CITRATE | toremifene citrate | TABLET;ORAL | 208813 | ANDA | Rising Pharmaceuticals, Inc. | 64980-404 | 64980-404-03 | 30 TABLET in 1 BOTTLE, PLASTIC (64980-404-03) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 60MG BASE | ||||
Approval Date: | Dec 4, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription